Mobile
Search
Advanced search
Multi-criteria search
Who are we ?
Log in
Sign up
Français
English
Kusajili – Clinical trials directory
Send this study to a contact
1
Your personal information
Your name
Your e-mail
Send me a copy
2
Your recipient's information
The name of your contact
Your contact email
3
Your message
Votre message
A 52 week randomised, controlled, open label, multicentre, multinational, parallel, treat-to-target trial comparing efficacy and safety of SIBA and insulin glargine both administered once daily in a basal-bolus regimen with insulin aspart as mealtime insulin in subjects with type 1 diabetes https://kusajili.fr:443/Trial/bhVp-SuG8k6IY0wQE3zY-g%24a-52-week-randomised-controlled-open-label-multicentre-multinational-parallel-treat-to-target-trial-comparing-efficacy-and-safe
I have read and accept the terms of use of the site and the Privacy Policy
Send your message